Related Experiment Videos

Anthracycline-induced inhibition of a calcium action potential in differentiated murine neuroblastoma cells

Cancer Research
|June 1, 1986
PubMed

Insights

Anthracyclines like doxorubicin and daunomycin inhibit calcium (Ca2+) dependent action potentials in neuroblastoma cells. This suggests a direct effect on cell membranes, potentially impacting calcium

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Differentiated neuroblastoma cells exhibit electrical excitability.
  • These cells generate action potentials where calcium (Ca2+) is the primary charge carrier.
  • Tetrodotoxin-resistant action potentials confirm Ca2+ dependence.

Purpose of the Study:

  • To investigate the effects of anthracyclines on Ca2+-dependent action potentials.
  • To determine the mechanism and dose-dependency of anthracycline-induced inhibition.
  • To explore the potential role of Ca2+ in cancer cells.

Main Methods:

  • Electrophysiological recordings from differentiated murine neuroblastoma cells (N1E-115).
  • Application of varying concentrations of doxorubicin and daunomycin.
  • Assessment of action potential amplitude and recovery after drug removal.

Main Results:

  • Doxorubicin (10(-8) M) rapidly inhibited Ca2+-dependent action potentials by up to 13%.
  • Higher doxorubicin concentrations (10(-5) M) caused 88% inhibition with no recovery.
  • Daunomycin (10(-6) M) induced 90% inhibition; daunomycin aglycone had no effect.

Conclusions:

  • Anthracyclines directly inhibit voltage-dependent Ca2+ channels in neuroblastoma cells.
  • Inhibition is rapid, dose-dependent, and suggests a cell membrane interaction.
  • Findings highlight the role of Ca2+ in electrically excitable cancer cells.

Related Concept Videos